预防期间出现对奥司他韦耐药的大流行性H1N1病毒。 - Suppr

Suppr

超能文献

Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.

作者信息

Baz Mariana, Abed Yacine, Papenburg Jesse, Bouhy Xavier, Hamelin Marie-Eve, Boivin Guy

出版信息

N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11.

DOI:10.1056/NEJMc0910060

PMID:19907034

Abstract

摘要

相似文献

Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.预防期间出现对奥司他韦耐药的大流行性H1N1病毒。

N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11.

First isolation of a oseltamivir-resistant influenza A (H1N1) strain in Argentina.在阿根廷首次分离出对奥司他韦耐药的甲型H1N1流感毒株。

Pediatr Infect Dis J. 2010 Apr;29(4):384. doi: 10.1097/INF.0b013e3181cd7244.

Global transmission of oseltamivir-resistant influenza.耐奥司他韦流感病毒的全球传播。

N Engl J Med. 2009 Mar 5;360(10):953-6. doi: 10.1056/NEJMp0900648. Epub 2009 Mar 2.

Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.一种耐多药的甲型H1N1大流行性流感病毒的出现。

N Engl J Med. 2010 Sep 30;363(14):1381-2. doi: 10.1056/NEJMc1003749.

Drug resistance. A 'wimpy' flu strain mysteriously turns scary.耐药性。一种“软弱”的流感毒株神秘地变得可怕起来。

Science. 2009 Feb 27;323(5918):1162-3. doi: 10.1126/science.323.5918.1162.

Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.检测与奥司他韦耐药相关的 H275Y 突变在严重大流行流感病毒 A/H1N1 09 感染中的快速出现。

Antiviral Res. 2010 Jul;87(1):16-21. doi: 10.1016/j.antiviral.2010.04.002. Epub 2010 Apr 10.

Simplified screening method for detecting oseltamivir resistant pandemic influenza A (H1N1) 2009 virus by a RT-PCR/restriction fragment length polymorphism assay.通过 RT-PCR/限制性片段长度多态性分析的简化方法检测奥司他韦耐药的大流行流感 A(H1N1)2009 病毒。

J Virol Methods. 2010 Dec;170(1-2):165-8. doi: 10.1016/j.jviromet.2010.09.005. Epub 2010 Sep 15.

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.2009年北卡罗来纳州两名接受预防治疗的夏令营营员感染对奥司他韦耐药的2009年甲型H1N1大流行性流感病毒

MMWR Morb Mortal Wkly Rep. 2009 Sep 11;58(35):969-72.

Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.抗病毒药物对2009年甲型H1N1流感病毒的敏感性。

Biochem Biophys Res Commun. 2009 Jul 31;385(3):390-4. doi: 10.1016/j.bbrc.2009.05.066. Epub 2009 May 20.

Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.季节性和大流行性甲型流感 A/H1N1 中出现的奥司他韦耐药性。

J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17.

引用本文的文献

Antiviral Therapy for HPAI and Reported Oseltamivir Resistance in Canada.加拿大高致病性禽流感的抗病毒治疗及报告的奥司他韦耐药性

J Assoc Med Microbiol Infect Dis Can. 2025 Jun 27;10(2):101-104. doi: 10.3138/jammi-2025-0307. eCollection 2025 Jun.

Integrated virtual screening and compound generation targeting H275Y mutation in the neuraminidase gene of oseltamivir-resistant influenza strains.针对奥司他韦耐药流感毒株神经氨酸酶基因H275Y突变的整合虚拟筛选和化合物生成

Mol Divers. 2025 Mar 14. doi: 10.1007/s11030-025-11163-0.

Molecular dynamics study on the effect of the N1 neuraminidase double mutant G147R/H274Y on oseltamivir sensitivity.N1神经氨酸酶双突变体G147R/H274Y对奥司他韦敏感性影响的分子动力学研究

RSC Adv. 2024 Dec 10;14(52):39017-39026. doi: 10.1039/d4ra07713j. eCollection 2024 Dec 3.

Drug resistance and possible therapeutic options against influenza A virus infection over past years.近年来抗流感 A 病毒感染的耐药性及可能的治疗选择。

Arch Microbiol. 2024 Nov 5;206(12):458. doi: 10.1007/s00203-024-04181-3.

AMMI Canada 2023 update on influenza: Management and emerging issues.加拿大AMMI 2023年流感最新情况：管理与新出现的问题

J Assoc Med Microbiol Infect Dis Can. 2023 Nov 29;8(3):176-185. doi: 10.3138/jammi-2023-07-12. eCollection 2023 Nov.

Multicenter, randomized controlled, open label evaluation of the efficacy and safety of arbidol hydrochloride tablets in the treatment of influenza-like cases.盐酸阿比多尔片治疗流感样病例的多中心、随机、对照、开放性评价疗效和安全性。

BMC Infect Dis. 2023 Sep 6;23(1):585. doi: 10.1186/s12879-023-08570-9.

Influenza antivirals and their role in pandemic preparedness.流感抗病毒药物及其在大流行准备中的作用。

Antiviral Res. 2023 Feb;210:105499. doi: 10.1016/j.antiviral.2022.105499. Epub 2022 Dec 23.

The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis.他汀类药物对流感病毒感染的患病率和死亡率的影响：一项系统评价和荟萃分析。

Arch Med Sci. 2022 Nov 7;18(6):1513-1524. doi: 10.5114/aoms/149633. eCollection 2022.

Use of antiviral drugs for seasonal influenza: Foundation document for practitioners-Update 2019.季节性流感抗病毒药物的使用：从业者基础文件 - 2019年更新版

J Assoc Med Microbiol Infect Dis Can. 2019 Jun 17;4(2):60-82. doi: 10.3138/jammi.2019.02.08. eCollection 2019 Jun.

Protein Disulfide Isomerase A3 Regulates Influenza Neuraminidase Activity and Influenza Burden in the Lung.蛋白二硫键异构酶 A3 调控流感神经氨酸酶活性和肺部流感病毒载量。

Int J Mol Sci. 2022 Jan 19;23(3):1078. doi: 10.3390/ijms23031078.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验